Target Price | $9.33 |
Price | $0.72 |
Potential |
1,199.00%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Tempest Therapeutics Inc 2026 .
The average Tempest Therapeutics Inc target price is $9.33.
This is
1,199.00%
register free of charge
$16.00
2,126.86%
register free of charge
$5.00
595.89%
register free of charge
|
|
A rating was issued by 4 analysts: 4 Analysts recommend Tempest Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Tempest Therapeutics Inc stock has an average upside potential 2026 of
1,199.00%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.50 | -1.24 |
21.47% | 17.33% | |
P/E | negative |
4 Analysts have issued a Tempest Therapeutics Inc forecast for earnings per share. The average Tempest Therapeutics Inc EPS is
This results in the following potential growth metrics and future valuations:
Tempest Therapeutics Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 28 2025 |
Scotiabank |
Locked
➜
Locked
|
Locked | Mar 28 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 10 2024 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 28 2025 |
Locked
Scotiabank:
Locked
➜
Locked
|
Mar 28 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 13 2024 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Nov 13 2024 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 10 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.